MARKET

CEROW

CEROW

CERo Therapeutics
NASDAQ
0.0143
-0.0010
-6.54%
Closed 12:29 04/17 EDT
OPEN
0.0153
PREV CLOSE
0.0153
HIGH
0.0166
LOW
0.0140
VOLUME
17.26K
TURNOVER
--
52 WEEK HIGH
0.1000
52 WEEK LOW
0.0030
MARKET CAP
--
P/E (TTM)
-0.0004
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CEROW last week (0407-0411)?
Weekly Report · 6d ago
CERO THERAPEUTICS HOLDINGS, INC. ANNOUNCES CRITICAL PATENT APPLICATION ALLOWANCES FROM THE U.S. PATENT OFFICE COVERING COMPANY’S LEAD COMPOUND CER-1236
Reuters · 04/10 12:15
Weekly Report: what happened at CEROW last week (0331-0404)?
Weekly Report · 04/07 09:44
CERO THERAPEUTICS HOLDINGS, INC. RECEIVES FDA CLEARANCE OF SECOND INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE PHASE 1 CLINICAL TRIAL OF LEAD COMPOUND CER-1236 IN SOLID TUMORS
Reuters · 03/31 12:15
Weekly Report: what happened at CEROW last week (0324-0328)?
Weekly Report · 03/31 09:48
Weekly Report: what happened at CEROW last week (0317-0321)?
Weekly Report · 03/24 09:44
CERO THERAPEUTICS HOLDINGS INC - ON TRACK FOR FIRST PATIENT DOSING IN H1 2025
Reuters · 03/19 12:15
Weekly Report: what happened at CEROW last week (0310-0314)?
Weekly Report · 03/17 09:48
More
About CEROW
CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company’s proprietary approach to T cell engineering, enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, which is designed to engage the body’s full immune repertoire to achieve optimized cancer therapy. Its cellular immunotherapy platform is focused on redirecting patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating CERo, which is referred to as chimeric engulfment receptor t cells (CER-T). The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies.

Webull offers CERo Therapeutics Holdings Inc stock information, including NASDAQ: CEROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CEROW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CEROW stock methods without spending real money on the virtual paper trading platform.